Gilde Healthcare Partners, a Utrecht, The Netherlands-based private equity firm specializing in healthcare, announced the launch of a new growth capital fund, Gilde Healthcare...
arGEN-X BV, a Rotterdam, The Netherlands-based biopharmaceutical company focused on the discovery and development of human antibodies, announced the successful second closing of its...
The European Investment Bank (EIB) and Netherlands' Royal Philips Electronics (AEX: PHI, NYSE: PHG) have signed a €200m loan agreement under the EIB's Risk-Sharing...
Kreatech Diagnostics, an Amsterdam, Netherlands-based biotechnology company focused on the development and commercialization of molecular diagnostics, has finalised a €2m financing round.Investors in the...
arGEN-X BV, a Rotterdam, The Netherlands-based biopharmaceutical company focused on the discovery and development of human antibodies, announced that its newly formed R&D subsidiary...
GreenPeak Technologies completed a €13m ($19m) Series B venture capital financing round.The round was led by exisiting backers Gimv and Robert Bosch Venture Capital...
BMEYE B.V., a provider cardiovascular monitoring systems, completed its 6m Series B financing round led by new investors Earlybird with participation from 360 Capital...
Euronext Paris and NYSE-quoted Alcatel-Lucent and BNP Paribas Lease Group teamed up to launch a multi-country financing program designed to support the communication solution...
arGEN-X BV, a dutch biopharmaceutical company focused on the discovery and development of human antibodies, announced the first closing of its € 9.5m Series...
ProFibrix, a Netherlands-based developer of innovative products for hemostasis and regenerative medicine, closed a $11m series B investment in an operation led by new...
